应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TVGN Tevogen Bio Holdings
盘后交易 01-13 19:11:53 EST
0.3138
-0.0112
-3.45%
盘后
0.3129
-0.0009
-0.29%
17:24 EST
最高
0.3291
最低
0.3119
成交量
59.54万
今开
0.3262
昨收
0.3250
日振幅
5.30%
总市值
6,235万
流通市值
770.43万
总股本
1.99亿
成交额
19.17万
换手率
2.43%
流通股本
2,455万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Tevogen Bio Holdings Inc.盘中异动 快速上涨6.10%报0.411美元
市场透视 · 2025-11-18
Tevogen Bio Holdings Inc.盘中异动 快速上涨6.10%报0.411美元
Tevogen宣布重大临床里程碑:扩展其针对急性和长期新冠的精准T细胞治疗的HLA覆盖范围
美股速递 · 2025-11-06
Tevogen宣布重大临床里程碑:扩展其针对急性和长期新冠的精准T细胞治疗的HLA覆盖范围
Tevogen Bio Holdings Inc.盘中异动 下午盘急速跳水5.44%
市场透视 · 2025-11-05
Tevogen Bio Holdings Inc.盘中异动 下午盘急速跳水5.44%
Tevogen Bio Holdings Inc.盘中异动 快速下挫5.39%
市场透视 · 2025-10-03
Tevogen Bio Holdings Inc.盘中异动 快速下挫5.39%
Tevogen Bio Holdings Inc - TVGN 116项目未来5年累计营收预测约65亿美元
美股速递 · 2025-09-10
Tevogen Bio Holdings Inc - TVGN 116项目未来5年累计营收预测约65亿美元
Tevogen Bio Holdings Inc.盘中异动 大幅上涨6.60%报0.960美元
市场透视 · 2025-08-11
Tevogen Bio Holdings Inc.盘中异动 大幅上涨6.60%报0.960美元
Tevogen Bio Holdings Inc.盘中异动 下午盘快速跳水5.36%
市场透视 · 2025-08-07
Tevogen Bio Holdings Inc.盘中异动 下午盘快速跳水5.36%
Tevogen Bio Holdings Inc.股价飙升22.41% 市值涨962.89万美元
市场透视 · 2025-08-06
Tevogen Bio Holdings Inc.股价飙升22.41% 市值涨962.89万美元
Tevogen Bio Holdings Inc.盘中异动 早盘快速下跌5.18%报1.08美元
市场透视 · 2025-03-10
Tevogen Bio Holdings Inc.盘中异动 早盘快速下跌5.18%报1.08美元
Tevogen Bio Holdings Inc.盘中异动 快速跳水5.35%
市场透视 · 2025-03-06
Tevogen Bio Holdings Inc.盘中异动 快速跳水5.35%
Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升5.93%报1.25美元
市场透视 · 2025-03-04
Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升5.93%报1.25美元
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.08%报1.22美元
市场透视 · 2025-03-04
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.08%报1.22美元
Tevogen Bio Holdings Inc.盘中异动 临近午盘股价大涨6.43%
市场透视 · 2025-02-28
Tevogen Bio Holdings Inc.盘中异动 临近午盘股价大涨6.43%
Tevogen Bio Holdings Inc.盘中异动 急速跳水5.44%
市场透视 · 2025-02-26
Tevogen Bio Holdings Inc.盘中异动 急速跳水5.44%
Tevogen Bio Holdings Inc.盘中异动 早盘大幅下跌5.89%报1.33美元
市场透视 · 2025-02-24
Tevogen Bio Holdings Inc.盘中异动 早盘大幅下跌5.89%报1.33美元
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.48%
市场透视 · 2025-02-21
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.48%
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.38%
市场透视 · 2025-02-19
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.38%
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.13%
市场透视 · 2025-02-15
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.13%
Tevogen Bio Holdings Inc.盘中异动 大幅下挫5.42%报1.57美元
市场透视 · 2025-02-14
Tevogen Bio Holdings Inc.盘中异动 大幅下挫5.42%报1.57美元
Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.48%报1.54美元
市场透视 · 2025-02-04
Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.48%报1.54美元
加载更多
公司概况
公司名称:
Tevogen Bio Holdings
所属市场:
NASDAQ
上市日期:
--
主营业务:
Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。
发行价格:
--
{"stockData":{"symbol":"TVGN","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings","latestPrice":0.3138,"timestamp":1768338000000,"preClose":0.325,"halted":0,"volume":595439,"hourTrading":{"tag":"盘后","latestPrice":0.3129,"preClose":0.3138,"latestTime":"17:24 EST","volume":7288,"amount":2356.75802032,"timestamp":1768343059524},"delay":0,"floatShares":24551700,"shares":198689921,"eps":-0.188139,"marketStatus":"盘后交易","change":-0.0112,"latestTime":"01-13 19:11:53 EST","open":0.3262,"high":0.329112,"low":0.3119,"amount":191706.42101468,"amplitude":0.05296,"askPrice":0.3514,"askSize":100,"bidPrice":0.3153,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.188139,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768352400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.325,"preHourTrading":{"tag":"盘前","latestPrice":0.3279,"preClose":0.325,"latestTime":"09:27 EST","volume":17172,"amount":5724.78006672,"timestamp":1768314426723},"postHourTrading":{"tag":"盘后","latestPrice":0.3129,"preClose":0.3138,"latestTime":"17:24 EST","volume":7288,"amount":2356.75802032,"timestamp":1768343059524},"volumeRatio":0.535},"requestUrl":"/m/hq/s/TVGN","defaultTab":"news","newsList":[{"id":"2584941954","title":"Tevogen Bio Holdings Inc.盘中异动 快速上涨6.10%报0.411美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584941954","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584941954?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:34","pubTimestamp":1763476478,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时34分,Tevogen Bio Holdings Inc.股票出现波动,股价急速上涨6.10%。截至发稿,该股报0.411美元/股,成交量5.7367万股,换手率0.03%,振幅3.95%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.20%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223438a70225ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223438a70225ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"1141099932","title":"Tevogen宣布重大临床里程碑:扩展其针对急性和长期新冠的精准T细胞治疗的HLA覆盖范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1141099932","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141099932?lang=zh_cn&edition=full","pubTime":"2025-11-06 04:20","pubTimestamp":1762374032,"startTime":"0","endTime":"0","summary":"Tevogen宣布重大临床里程碑:扩展其针对急性和长期新冠的精准T细胞治疗的HLA覆盖范围","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2581834794","title":"Tevogen Bio Holdings Inc.盘中异动 下午盘急速跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581834794?lang=zh_cn&edition=full","pubTime":"2025-11-05 03:09","pubTimestamp":1762283362,"startTime":"0","endTime":"0","summary":"北京时间2025年11月05日03时09分,Tevogen Bio Holdings Inc.股票出现波动,股价快速下跌5.44%。截至发稿,该股报0.556美元/股,成交量26.711万股,换手率0.14%,振幅5.71%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.03%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503092297540342&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110503092297540342&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2572665597","title":"Tevogen Bio Holdings Inc.盘中异动 快速下挫5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572665597","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572665597?lang=zh_cn&edition=full","pubTime":"2025-10-03 22:08","pubTimestamp":1759500498,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日22时08分,Tevogen Bio Holdings Inc.股票出现异动,股价急速下跌5.39%。截至发稿,该股报0.737美元/股,成交量15.9692万股,换手率0.08%,振幅6.16%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.05%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003220818a4526c16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003220818a4526c16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"1153465336","title":"Tevogen Bio Holdings Inc - TVGN 116项目未来5年累计营收预测约65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1153465336","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153465336?lang=zh_cn&edition=full","pubTime":"2025-09-10 03:18","pubTimestamp":1757445502,"startTime":"0","endTime":"0","summary":"Tevogen Bio Holdings Inc - TVGN 116项目未来5年累计营收预测约65亿美元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2558661235","title":"Tevogen Bio Holdings Inc.盘中异动 大幅上涨6.60%报0.960美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558661235?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:59","pubTimestamp":1754927964,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时59分,Tevogen Bio Holdings Inc.股票出现异动,股价快速上涨6.60%。截至发稿,该股报0.960美元/股,成交量39.07万股,换手率0.20%,振幅9.99%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.22%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811235924a6dfea25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811235924a6dfea25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2557304881","title":"Tevogen Bio Holdings Inc.盘中异动 下午盘快速跳水5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557304881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557304881?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:56","pubTimestamp":1754506612,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时56分,Tevogen Bio Holdings Inc.股票出现异动,股价急速下挫5.36%。截至发稿,该股报0.945美元/股,成交量212.958万股,换手率1.10%,振幅8.01%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.27%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080702565294d3ef8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080702565294d3ef8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2557162283","title":"Tevogen Bio Holdings Inc.股价飙升22.41% 市值涨962.89万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557162283","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557162283?lang=zh_cn&edition=full","pubTime":"2025-08-06 02:32","pubTimestamp":1754418744,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日02时32分,Tevogen Bio Holdings Inc.股票出现异动,股价快速上涨22.41%。截至发稿,该股报1.215美元/股,成交量20.172万股,换手率0.10%,振幅6.04%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为3.93%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060232249735d2d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508060232249735d2d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2518527981","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速下跌5.18%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518527981?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:01","pubTimestamp":1741618870,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时01分,Tevogen Bio Holdings Inc.股票出现波动,股价快速跳水5.18%。截至发稿,该股报1.08美元/股,成交量11.0718万股,换手率0.06%,振幅5.27%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023011198a2b2d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023011198a2b2d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2517940697","title":"Tevogen Bio Holdings Inc.盘中异动 快速跳水5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517940697","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517940697?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:48","pubTimestamp":1741196930,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时48分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下挫5.35%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.20%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014850abe9e98d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014850abe9e98d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2516677087","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅拉升5.93%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677087?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:47","pubTimestamp":1741099627,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时47分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅上涨5.93%。截至发稿,该股报1.25美元/股,成交量15.5608万股,换手率0.09%,振幅3.39%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.45%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042247089639497e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503042247089639497e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2516655652","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.08%报1.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516655652","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516655652?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:06","pubTimestamp":1741025204,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时06分,Tevogen Bio Holdings Inc.股票出现异动,股价快速下挫5.08%。截至发稿,该股报1.22美元/股,成交量58.3924万股,换手率0.33%,振幅8.20%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.23%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304020644989a40df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304020644989a40df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2514387794","title":"Tevogen Bio Holdings Inc.盘中异动 临近午盘股价大涨6.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387794?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:41","pubTimestamp":1740674462,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时41分,Tevogen Bio Holdings Inc.股票出现异动,股价急速拉升6.43%。截至发稿,该股报1.32美元/股,成交量15.4541万股,换手率0.09%,振幅4.44%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.60%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800410398952a4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022800410398952a4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2514011891","title":"Tevogen Bio Holdings Inc.盘中异动 急速跳水5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514011891?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:18","pubTimestamp":1740500335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时18分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅跳水5.44%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.59%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001855abdc97ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226001855abdc97ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2513187720","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅下跌5.89%报1.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513187720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513187720?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409333,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分,Tevogen Bio Holdings Inc.股票出现异动,股价急速跳水5.89%。截至发稿,该股报1.33美元/股,成交量16.2036万股,换手率0.09%,振幅4.95%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.24%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230213962ea093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230213962ea093&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2513294469","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513294469","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513294469?lang=zh_cn&edition=full","pubTime":"2025-02-21 23:33","pubTimestamp":1740151998,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日23时33分,Tevogen Bio Holdings Inc.股票出现异动,股价急速跳水5.48%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.09%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233318abd7bd64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221233318abd7bd64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2512162675","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512162675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512162675?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:08","pubTimestamp":1739894881,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时08分,Tevogen Bio Holdings Inc.股票出现异动,股价快速拉升5.38%。截至发稿,该股报1.67美元/股,成交量39.7288万股,换手率0.23%,振幅4.99%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.83%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190008019627a899&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190008019627a899&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2511618168","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511618168","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511618168?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:14","pubTimestamp":1739553295,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时14分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下挫5.13%。截至发稿,该股报1.48美元/股,成交量45.9814万股,换手率0.26%,振幅6.10%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.54%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215011455962340b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215011455962340b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2511578128","title":"Tevogen Bio Holdings Inc.盘中异动 大幅下挫5.42%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511578128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511578128?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:14","pubTimestamp":1739466887,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日01时14分,Tevogen Bio Holdings Inc.股票出现波动,股价急速下跌5.42%。截至发稿,该股报1.57美元/股,成交量64.4783万股,换手率0.37%,振幅6.63%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.84%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021401144798844bf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021401144798844bf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2509668294","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.48%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509668294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509668294?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:48","pubTimestamp":1738684089,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时48分,Tevogen Bio Holdings Inc.股票出现波动,股价急速拉升5.48%。截至发稿,该股报1.54美元/股,成交量32.1421万股,换手率0.18%,振幅8.22%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.80%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204234810a23937f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204234810a23937f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":-0.0947},{"period":"1month","weight":-0.1945},{"period":"3month","weight":-0.5378},{"period":"6month","weight":-0.7358},{"period":"1year","weight":-0.7759},{"period":"ytd","weight":-0.0184}],"compareEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0497},{"period":"6month","weight":0.1136},{"period":"1year","weight":0.1975},{"period":"ytd","weight":0.0194}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.024581},{"month":2,"riseRate":0.75,"avgChangeRate":0.093777},{"month":3,"riseRate":0.5,"avgChangeRate":-0.166085},{"month":4,"riseRate":0.5,"avgChangeRate":-0.189171},{"month":5,"riseRate":0.25,"avgChangeRate":0.008552},{"month":6,"riseRate":0.25,"avgChangeRate":-0.034979},{"month":7,"riseRate":0.5,"avgChangeRate":-0.078575},{"month":8,"riseRate":0.5,"avgChangeRate":-0.064152},{"month":9,"riseRate":0.5,"avgChangeRate":-0.105281},{"month":10,"riseRate":0.75,"avgChangeRate":1.418967},{"month":11,"riseRate":0.5,"avgChangeRate":-0.189646},{"month":12,"riseRate":0.5,"avgChangeRate":-0.111833}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings","nameEN":"Tevogen Bio Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tevogen Bio Holdings,TVGN,Tevogen Bio Holdings股票,Tevogen Bio Holdings股票老虎,Tevogen Bio Holdings股票老虎国际,Tevogen Bio Holdings行情,Tevogen Bio Holdings股票行情,Tevogen Bio Holdings股价,Tevogen Bio Holdings股市,Tevogen Bio Holdings股票价格,Tevogen Bio Holdings股票交易,Tevogen Bio Holdings股票购买,Tevogen Bio Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings(TVGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings(TVGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}